Full-Time
Document Management Specialist
Quality and Pharmaceutical Affairs
LFB
1,001-5,000 employees
Public health biopharmaceuticals via plasma-derived products
No salary listed
Alès, France
In Person
 Administrative & Executive Assistance (1) |
|---|
Get referred to LFB
See people who can refer or advise you
- A BTS-level training in information and documentation management, or experience as an assistant seeking professional development.
- Proficiency with Microsoft Office.
- Experience using tools specific to document management, including an electronic document management system.
- Basic English skills.
- A successful initial experience in the pharmaceutical industry.
- The ability to communicate, work collaboratively, and work cross-functionally.
- Participate in defining and structuring document-management repositories and systems for the assigned scope.
- Ensure the regulatory, quality, and contractual compliance of document-management practices.
- Ensure the traceability and reliability of document data across the assigned scope.
- Track documents throughout their lifecycle, from creation or update through archiving.
- Provide authors with templates for documents to be created or revised.
- Verify that documents comply with the instructions in the document-management operating procedure; perform quality-control checks and flag missing or expiring documents, formatting inconsistencies, and distribution issues.
- Register documents in the electronic document management system and assign their associated attributes.
- Organize and track document-signature workflows, set documents to applicable status, and ensure their distribution.
- Participate in improving the business document-management system.
- Perform document self-assessments and compliance checks according to internal processes, and lead the handling of discrepancies.
- Provide expertise when establishing document-management rules with users.
- Physically archive quality documentation in accordance with applicable procedures.
LFB is a French biopharmaceutical company that develops and manufactures medicines from plasma and biotech products. It collects plasma, fractionates it into medicines, and also produces recombinant proteins for rare diseases in immunology and hemostasis, sold in many countries. It stands out because it started as a state-initiated public health mission and remains state-owned with the French State as sole shareholder, plus vertical integration through acquisitions of plasma collection firms. Its goal is to ensure a reliable supply of essential medicines for public health while growing as a global biopharma player.
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Courcebœufs, France
Founded
1994
Get referred to LFB
See people who can refer or advise you
Simplify's Take
What believers are saying
- Amber Plasma added 12 Czech centers in 2024, lifting Europlasma to 24 centers.
- Arras began immunoglobulin production in November 2025, expanding supply and market share.
- LFB's 2026 Sartorius collaboration supports biomanufacturing scale-up and process reliability.
What critics are saying
- Lille's Annex 1 GMP remediation caused workshop delays and strained output in 2025.
- Plasma drug shortages persisted into 2026, forcing ANSM-backed substitution guidance for multiple products.
- If Arras or Lille slip again, France's plasma supply dependence becomes LFB's existential weak point.
What makes LFB unique
- State-backed French plasma specialist with full-chain control through Europlasma and Arras.
- Arras opened production in 2024, aiming to triple fractionation capacity by 2025.
- LFB sells 15 medicines across roughly 30 countries in immunology, hemostasis, intensive care.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
401(k) Retirement Plan
Remote Work Options
Unlimited Paid Time Off
Flexible Work Hours
Paid Vacation
Hybrid Work Options
Wellness Program
Mental Health Support
Phone/Internet Stipend
Home Office Stipend
Stock Options
Company Equity
Conference Attendance Budget
Family Planning Benefits
Fertility Treatment Support
Professional Development Budget
Education allowance
Tuition Reimbursement
Growth & Insights and Company News
6 month growth
↑ 6%1 year growth
↑ 6%2 year growth
↑ 6%Title: "LFB Acquires Amber Plasma in the Czech Republic" LFB and its subsidiary Europlasma have acquired Amber Plasma, which operates 12 plasma collection centers in the Czech Republic. This acquisition increases Europlasma's total to 24 centers in Central Europe, enhancing LFB's plasma collection capacity. The move supports LFB's goal to meet growing patient demand and will aid in the launch of a new production site in Arras, France, tripling its medication production capacity.